@xconomy.com 3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com 3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@techcrunch.com 5 years ago
RDMD attacks rare diseases with data mined from health records
@Primary_Immune 5 years ago
The Remarkable Story Behind the Story of the First FDA Approved #Marijuana-Based Drug (For Rare #Epilepsy) | https://www.cincinnati.com/story/news/2018/06/27/cincinnati-test-site-weed-drug-fda-has-just-approved/732043002/ #MedED #ITRTG #BigData #science #technology #genetics #SNRTG #biotech #Dravet #MedicalMarijuana #inspiration #RareDisease #SciComm By @apsaker https://t.co/eNC61FgOhS
@xconomy.com 5 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed